These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 23989971)
1. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up. Moreno-Moraga J; Smarandache A; Pascu ML; Royo J; Trelles MA Phlebology; 2014 Dec; 29(10):658-66. PubMed ID: 23989971 [TBL] [Abstract][Full Text] [Related]
2. Effects of 1064-nm Nd:YAG long-pulse laser on polidocanol microfoam injected for varicose vein treatment: a controlled observational study of 404 legs, after 5-year-long treatment. Moreno-Moraga J; Pascu ML; Alcolea JM; Smarandache A; Royo J; David F; Trelles MA Lasers Med Sci; 2019 Sep; 34(7):1325-1332. PubMed ID: 30707327 [TBL] [Abstract][Full Text] [Related]
3. Nd:Yag laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias (CLaCS method): A triple-blind randomized clinical trial comparing two sclerosing agents associated with same laser patterns. Fonseca MM; Mocelin FJ; Grill MH; Gianesini S; Miyake K; Argenta R; Pereira AH Phlebology; 2023 Apr; 38(3):165-171. PubMed ID: 36657386 [TBL] [Abstract][Full Text] [Related]
4. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence. Todd KL; Wright DI; Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535 [TBL] [Abstract][Full Text] [Related]
5. Durability of treatment effect with polidocanol endovenous microfoam on varicose vein symptoms and appearance (VANISH-2). Todd KL; Wright DI; J Vasc Surg Venous Lymphat Disord; 2015 Jul; 3(3):258-264.e1. PubMed ID: 26992303 [TBL] [Abstract][Full Text] [Related]
6. Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial. Parlar B; Blazek C; Cazzaniga S; Naldi L; Kloetgen HW; Borradori L; Buettiker U J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):549-54. PubMed ID: 25069999 [TBL] [Abstract][Full Text] [Related]
7. Comparison and sequential study of long pulsed Nd:YAG 1,064 nm laser and sclerotherapy in leg telangiectasias treatment. Levy JL; Elbahr C; Jouve E; Mordon S Lasers Surg Med; 2004; 34(3):273-6. PubMed ID: 15022257 [TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy: a study comparing polidocanol in foam and liquid form. Uncu H Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346 [TBL] [Abstract][Full Text] [Related]
9. Treatment of varicose and telangiectatic leg veins: double-blind prospective comparative trial between aethoxyskerol and sotradecol. Goldman MP Dermatol Surg; 2002 Jan; 28(1):52-5. PubMed ID: 11991271 [TBL] [Abstract][Full Text] [Related]
10. Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial. Bertanha M; Sobreira ML; Pinheiro Lúcio Filho CE; de Oliveira Mariúba JV; Farres Pimenta RE; Jaldin RG; Moroz A; Moura R; Rollo HA; Yoshida WB Trials; 2014 Dec; 15():497. PubMed ID: 25527165 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Rabe E; Otto J; Schliephake D; Pannier F Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905 [TBL] [Abstract][Full Text] [Related]
13. Comparative pilot study evaluating the treatment of leg veins with a long pulse ND:YAG laser and sclerotherapy. Coles CM; Werner RS; Zelickson BD Lasers Surg Med; 2002; 30(2):154-9. PubMed ID: 11870796 [TBL] [Abstract][Full Text] [Related]
14. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Rao J; Wildemore JK; Goldman MP Dermatol Surg; 2005 Jun; 31(6):631-5; discussion 635. PubMed ID: 15996411 [TBL] [Abstract][Full Text] [Related]
15. Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline. Peterson JD; Goldman MP; Weiss RA; Duffy DM; Fabi SG; Weiss MA; Guiha I Dermatol Surg; 2012 Aug; 38(8):1322-30. PubMed ID: 22620717 [TBL] [Abstract][Full Text] [Related]
16. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study). Rabe E; Schliephake D; Otto J; Breu FX; Pannier F Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861 [TBL] [Abstract][Full Text] [Related]
18. Sclerotherapy for leg telangiectasia--a blinded comparative trial of polidocanol and hypertonic saline. McCoy S; Evans A; Spurrier N Dermatol Surg; 1999 May; 25(5):381-5; discussion 385-6. PubMed ID: 10469077 [TBL] [Abstract][Full Text] [Related]
19. Pulsed-dye laser treatment of leg telangiectasia: with and without simultaneous sclerotherapy. Goldman MP; Fitzpatrick RE J Dermatol Surg Oncol; 1990 Apr; 16(4):338-44. PubMed ID: 2324370 [TBL] [Abstract][Full Text] [Related]
20. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance. King JT; O'Byrne M; Vasquez M; Wright D; Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):784-93. PubMed ID: 26384639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]